Literature DB >> 10884226

Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.

D S Geller1, A Farhi, N Pinkerton, M Fradley, M Moritz, A Spitzer, G Meinke, F T Tsai, P B Sigler, R P Lifton.   

Abstract

Hypertension and pregnancy-related hypertension are major public health problems of largely unknown causes. We describe a mutation in the mineralocorticoid receptor (MR), S810L, that causes early-onset hypertension that is markedly exacerbated in pregnancy. This mutation results in constitutive MR activity and alters receptor specificity, with progesterone and other steroids lacking 21-hydroxyl groups, normally MR antagonists, becoming potent agonists. Structural and biochemical studies indicate that the mutation results in the gain of a van der Waals interaction between helix 5 and helix 3 that substitutes for interaction of the steroid 21-hydroxyl group with helix 3 in the wild-type receptor. This helix 5-helix 3 interaction is highly conserved among diverse nuclear hormone receptors, suggesting its general role in receptor activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884226     DOI: 10.1126/science.289.5476.119

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  98 in total

Review 1.  Matching the right drug to the right patient in essential hypertension.

Authors:  M J Brown
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

Review 2.  Hyperaldosteronism: recent concepts, diagnosis, and management.

Authors:  R Foo; K M O'Shaughnessy; M J Brown
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

3.  Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.

Authors:  So-Jung Park; Irina Kufareva; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

Review 4.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 5.  Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors.

Authors:  Ossama B Kashlan; Thomas R Kleyman
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

6.  A novel vasopressin-induced transcript promotes MAP kinase activation and ENaC downregulation.

Authors:  Marie Nicod; Stéphanie Michlig; Marjorie Flahaut; Miguel Salinas; Nicole Fowler Jaeger; Jean-Daniel Horisberger; Bernard C Rossier; Dmitri Firsov
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 7.  The molecular basis of blood pressure variation.

Authors:  Hakan R Toka; Jacob M Koshy; Ali Hariri
Journal:  Pediatr Nephrol       Date:  2012-07-05       Impact factor: 3.714

8.  Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertension.

Authors:  Bei Sun; Bindu Chamarthi; Jonathan S Williams; Alexander W Krug; Jessica Lasky-Su; Benjamin A Raby; Paul N Hopkins; Xavier Jeunemaitre; Claudio Ferri; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-06-20       Impact factor: 5.958

9.  High aldosterone, hypertension and adrenal adenoma in a 36-year-old pregnant patient: Is this primary aldosteronism?

Authors:  Amanda J Berberich; Deborah Penava; Dongmei Sun; Arlene MacDougall; Andrea Lum; Stan Van Uum
Journal:  Obstet Med       Date:  2018-11-04

10.  Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels.

Authors:  F L Fernandes-Rosa; A C Bueno; R Molina de Souza; M de Castro; J Ernesto dos Santos; M C Foss; M-C Zennaro; H Bettiol; M A Barbieri; S R Antonini
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.